Why is Akums Drugs falling/rising?

As of 28-Aug, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 467.00, down by 9.55 points or 2.0%. The stock has underperformed its sector by 1.16% today and has been on a consecutive downward trend for the last four days, resulting in a total return of -3.21% over this period. Additionally, the stock has significantly underperformed in the longer term, with a staggering -47.15% return over the past year, while its profits have risen by an impressive 1362%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a 2.4 Price to Book Value, the company has shown poor long-term growth, with net sales growing at only 6.10% annually over the last five years.
In the broader market context, the stock's performance has been notably weaker than the benchmark, with the Sensex declining by only 2.34% over the same one-week period. The stock's recent performance reflects a concerning trend, as it has consistently underperformed against the BSE500 over the last three years, one year, and three months. The flat results reported in June, including a significant drop in PAT and the lowest operating profit to interest ratio, further contribute to the negative sentiment surrounding the stock. This combination of poor short-term performance, disappointing financial results, and underwhelming long-term growth prospects has led to a decline in investor confidence, resulting in the current downward movement of Akums Drugs' stock price.